smooth rock formations

IDAC Support

1 minute read

Published: April 6th, 2021

Phastar was awarded as a preferred supplier to a top 20 pharmaceutical sponsor, supporting five new studies per year. Each study was several years in length, with IDMC meetings taking place every 3-6 months. Phastar worked with this pharmaceutical sponsor through two models for IDAC support; model one offering independent programming of the blinded and unblinded IDMC package, with model two utilising sponsor programming code to produce blinded and unblinded IDMC package.

Complete the form below to read the full case study

Related articles

Delivering Integrated Safety and Efficacy Analyses in Cushing Syndrome

Delivering Integrated Safety and Efficacy Analyses in Cushing Syndrome

October 6th, 2025 1 minute read

When faced with evolving analysis plans, minimal client infrastructure, and shifting output volumes, Phastar delivere...

Delivering a Complex ISS in Autoimmune Pulmonary Alveolar Proteinosis

Delivering a Complex ISS in Autoimmune Pulmonary Alveolar Proteinosis

September 26th, 2025 1 minute read

Phastar supported a sponsor in delivering a high-quality Integrated Summary of Safety (ISS) for a rare disease progra...

Delivering Integrated Efficacy and Safety Summaries in VMS

Delivering Integrated Efficacy and Safety Summaries in VMS

September 26th, 2025 1 minute read

Integrating efficacy and safety data across multiple studies is never simple—especially when patient-reported outcome...